Skip to content

Ultra Processed Foods Consumption and Impact in Rheumatic Diseases.

Impact of Ultra-processed Foods in a Population of Patients With Chronic Rheumatic Diseases (Rheumatoid Arthritis, Spondyloarthritis, Osteoarthritis).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06776965
Acronym
NUTRIRIC
Enrollment
240
Registered
2025-01-15
Start date
2025-03-31
Completion date
2026-11-30
Last updated
2025-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Rheumatoid Arthritis, Spondyloarthritis

Keywords

Ultra-processed food, osteoarthritis, rheumatoid arthritis, spondyloarthritis

Brief summary

Ultra-processed foods (UPF) represent one of the mainstays of today's diet. They are defined by the NOVA classification system. It was demonstrated that UPF consumption was associated with activity of inflammatory bowel diseases with underlying mechanisms not fully identified yet. It is suspected that UPF constituents could modify the gut microbiota, increase intestinal barrier permeability and directly engage immune surveillance systems, effects that could individually or synergistically increase the risk of immunomediated diseases. As some pathophysiological mechanisms are shared among IBD and rheumatic diseases, we have wondered if UPF consumption could be associated with increased risk of rheumatic disease and/or with their activity. Our primary aim will be to study the pattern of UPF consumption in patients with rheumatic diseases. Our secondary objectives will be to study the activity of diseases according to UPF consumption.

Interventions

Self administered dietary questionnaire at baseline, 6 and 12 months.

OTHEREvaluation of disease activity (DAS-28, ASDAS, EVA, number of swollen joints, number of painful joint, nocturnal pain, morning stiffness)

Self administered questionnaire of disease activity at baseline, 6 and 12 months.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * chronic rheumatic disease (Rheumatoid arthritis, spondyloarthritis, osteoarthritis) * ability to perform questionnaires

Exclusion criteria

* Judicial protection measure * Refusal to participate in the study * Suffering from 2 rheumatic disease simultaneously

Design outcomes

Primary

MeasureTime frameDescription
Describe the consumption of ultra-processed foods in patients with chronic inflammatory rheumatismAt baselineDescribes the consumption of ultra-processed foods in patients with chronic inflammatory rheumatism using a self-assessment questionnaire (Score UPF Nova Screener) completed at baseline, 6 and 12 months.

Countries

France

Contacts

Primary ContactMaxime AUROUX, MD
Maxime.auroux@chu-lyon.fr+33472117479

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026